HR | 95% CI | P | ||
---|---|---|---|---|
Age | 0.02 | |||
YP (≤45 years) | 0.37 | 0.15 – 0.72 | ||
OP (≥75 years) | 1.00 | (reference) | ||
pTNM stage | 0.002 | |||
pT1+pT2 | 1.00 | (reference) | ||
pT3 +pT4 | 3.46 | 1.72 – 12.49 | ||
Nodal status | < 0.001 | |||
N0 | 1.00 | (reference) | ||
N1, N2 | 5.57 | 1.98 – 15.64 | ||
M status | < 0.001 | |||
M0 | 1.00 | (reference) | ||
M1 | 35.99 | 9.88 – 131.02 | ||
Tumor grade | < 0.001 | |||
G1+G2 | 1.00 | (reference) | ||
G3 | 4.01 | 0.73 – 21.94 | ||
Tumor diameter | < 0.01 | |||
< 7 cm | 1.00 | (reference) | ||
≥7 cm | 1.76 | 0.40 – 10.38 | ||
Histological subtype | ||||
Clear-cell | 1.00 | (reference) | ||
Papillary | 1.43 | 0.46 – 4.97 | 0.54 | |
Chromophobe | 1.06 | 0.23 – 4.78 | 0.92 | |
Other histological types | 1.15 | 0.15 – 8.96 | 0.89 | |
Sex | ||||
Male | 1.00 | (reference) | ||
Female | 0.61 | 0.24 – 1.56 | 0.29 | |
Clinical presentation | 0.002 | |||
Asymptomatic | 1.00 | (reference) | ||
Symptomatic | 4.41 | 1.71 – 11.37 |